Skip to main content
Equibles

Jeffrey Jones

CFO

Cohu Inc (COHU)
Cullinan Therapeutics, Inc. (CGEM)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cohu Inc publishes a filing, an earnings call transcript or a press release.

Get COHU alerts

About Jeffrey Jones

Jeffrey Jones is recorded as CFO at Cohu Inc (COHU). The newest filing on record that lists Jeffrey Jones as CFO at Cohu Inc (COHU) is dated April 2, 2026. The proxy statement of Cullinan Therapeutics, Inc. reports total compensation of $2,221,578 for Jeffrey Jones in fiscal 2025, including a base salary of $529,804. Disclosed compensation is on record for 7 fiscal years. Jeffrey Jones has spoken on 10 earnings calls across 1 company, most recently for Cohu Inc on October 29, 2025. Cohu Inc is classified in the Semiconductor Equipment & Materials industry within the Technology sector. Cullinan Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cohu Inc includes Luis Muller (CEO and Board Member), Thomas D. Kampfer (General Counsel), Andreas ("Andy") W. Mattes (Board Member) and 7 others.

Jeffrey Jones on recent calls

“Good afternoon, and welcome to our conference call discussing Cohu's third quarter 2025 financial results and our outlook for the fourth quarter of 2025. I'm joined today by Luis Müller, Cohu's President and CEO.”
CFO, Cohu Inc Q3 FY2025 Earnings Call ·
“Good afternoon, and welcome to our conference call to discuss Cohu's second quarter 2025 results and third quarter 2025 outlook. I'm joined today by our President and CEO, Luis Muller.”
CFO, Cohu Inc Q2 FY2025 Earnings Call ·
“Good afternoon, and welcome to our conference call to discuss Cohu's fourth quarter 2024 results and first quarter 2025 outlook. I'm joined today by our President and CEO, Luis Muller.”
CFO, Cohu Inc Q4 FY2024 Earnings Call ·
“Good afternoon, and welcome to our conference call to discuss Cohu's third quarter 2024 results and fourth quarter outlook. I'm joined today by our President and CEO, Luis Muller.”
CFO, Cohu Inc Q3 FY2024 Earnings Call ·
“Good afternoon, and welcome to our conference call to discuss Cohu's first quarter 2024 results and second quarter outlook. I'm joined today by our President and CEO, Luis Muller.”
CFO, Cohu Inc Q1 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at Cohu Inc

Leadership on record at Cullinan Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cullinan Therapeutics, Inc. (CGEM) $529,804 $2,221,578
2025 Cohu Inc (COHU) $455,000 $1,681,161
2024 Cullinan Therapeutics, Inc. (CGEM) $511,888 $3,388,014
2024 Cohu Inc (COHU) $455,000 $1,826,355
2023 Cullinan Therapeutics, Inc. (CGEM) $492,200 $2,421,669
2023 Cohu Inc (COHU) $452,231 $2,466,610
2022 Cohu Inc (COHU) $432,846 $2,117,055
2021 Cohu Inc (COHU) $404,232 $1,853,488
2020 Cohu Inc (COHU) $358,081 $1,356,510
2019 Cohu Inc (COHU) $371,257 $1,125,541

Recent activity